UCSC Genome Browser and BRCA Exchange: Data Resources for Clinical Variant Interpretation
Join Drs. Maximilian Haeussler and Melissa Cline from the University of California Santa Cruz (UCSC) Genomics Institute as they discuss data resources for clinical variant interpretation within their UCSC programs.
Dr. Haeussler is the co-principal investigator for UCSC Genome Browser, which offers access to genome sequence data from a variety of vertebrate and invertebrate species, and major model organisms.
Dr. Cline is the program manager of the UCSC BRCA Exchange, an open-source data repository sponsored by NCI and NIH. It’s designed to advance the understanding of the genetic basis of breast, ovarian, pancreatic, and other cancers by pooling data on BRCA1/2 genetic variants and corresponding clinical data from around the world.
This presentation is a part of the Sequencing Strategies for Population and Cancer Epidemiology Studies (SeqSPACE) webinar series. Hosted by NCI’s Epidemiology and Genomics Research Program, this series provides an opportunity for NCI grantees and other interested individuals to share lessons learned and information regarding the application of next generation sequencing to cancer epidemiology studies.
Dr. Haeussler the co-principal investigator for the UCSC Genome Browser. He works on single-cell visualization and has interests in biomedical text mining and genome annotation.
Dr. Cline is an associate research scientist at the UCSC Genomics Institute and the program manager of the BRCA Exchange. She leads a team of software engineers and graduate students to pioneer methods for sharing genetic data.
Upcoming Events
- AI-Driven Spatial Transcriptomics Unlocks Large-Scale Breast Cancer Biomarker Discovery from HistopathologyMay 07, 2025Co-clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting 2025—Celebrating A Ten-Year MilestoneMay 07, 2025 - May 08, 2025Workshop Series: Synthetic and Systems Approaches to Interrogate Spatiotemporal Processes in CancerMay 13, 2025 - May 20, 2025Pediatric Preclinical In Vivo Testing (PIVOT) Program: Advancing Targeted Therapies for Childhood CancersMay 13, 2025Agentic AI in Cancer ResearchMay 27, 2025